Gene therapy for retinal degeneration may harbour blindness cure
October 17th, 2008 - 2:05 pm ICT by ANI - Send to a friend:Washington, Oct 17 (ANI): Researchers from Massachusetts General Hospital (MGH) have successfully restored vision in mice with retinal degeneration, using gene therapy a development that could lead to blindness cure.
The team was able to restore useful vision to mice with degeneration of the light-sensing retinal rods and cones, a common cause of human blindness, thus building hope that the technique may someday treat retinitis pigmentosa and macular degeneration.
“This is a proof of principle that someday we may be able to repair blindness in people with conditions like retinitis pigmentosa and macular degeneration,” said Richard Masland, PhD, director of the Cellular Neurobiology Laboratory in the MGH Department of Neurosurgery.
“There are several limitations we need to overcome before we can begin clinical trials, but I”m optimistic that this work may someday make a big difference for people who otherwise would have no vision at all,” he added.
For the study the researchers examined the effect of expressing the light-sensitive protein melanopsin in retinal ganglion cells.
These specialized neurons receive light signals from the rods and cones and carry those signals into the brain via the optic nerve
The team used the standard viral vector adeno-associated virus to deliver the gene encoding melanopsin throughout the retinas of mice whose rod and cone photoreceptors had degenerated from lack of a crucial protein.
They found that after four weeks, melanopsin normally produced in 1 percent of retinal ganglion cells was found in about 10 percent of ganglion cells in the treated eyes but not in eyes that received a sham injection.
Further analysis of revealed that all melanopsin-expressing cells responded to light.
The researchers found that the treated mice which otherwise would have been essentially blind had enough vision to find a darkened refuge in an otherwise brightly lit area.
“The same level of melanopsin expression in a human retina might allow someone who otherwise would be totally blind to read newspaper headlines, but the slowness of the response would be a problem,” said Masland.
The report appears in the Proceedings of the National Academy of Sciences. (ANI)
Related Stories
- Gene therapy could help blind people see again - October 17, 2008
- Retinal transplant shows promise for improved vision - July 13, 2008
- Awakening dormant stem cells holds hope for regenerating damaged retina - March 19, 2008
- Retina transplants benefit patients with retinal degeneration - July 11, 2008
- Scientists uncover microRNA role in sight loss - November 22, 2007
- Retinal transplants hold promise for patients with blindness - September 9, 2008
- Blind mice see the light after algae protein treatment - April 28, 2008
- New drug may harbour hope for age-related macular degeneration cure - November 30, 2007
- Indian-origin researchers study may help develop pills for body clock related conditions - June 11, 2008
- Indian-origin researchers study may help develop pills for body clock related conditions (Re-issue - June 12, 2008
- Scientists unveil first gene linked with dry macular degeneration - August 28, 2008
- Implantable prosthesis to restore retinal-disease caused vision loss developed - May 30, 2008
- How a diet rich in antioxidants prevents macular degeneration - August 20, 2008
- Brains of vision loss patients reorganise their neural connections - November 21, 2008
- Blood vessel protein opens path to treat macular degeneration, diabetic retinopathy - March 17, 2008
- National
- cellular neurobiology laboratory
- cone photoreceptors
- gene therapy
- human blindness
- light signals
- macular degeneration
- masland
- massachusetts general hospital
- melanopsin
- mgh
- mice
- neurosurgery
- optic nerve
- phd director
- retinal degeneration
- retinal ganglion cells
- retinas
- rods and cones
- sham
- viral vector
Posted in National, |

